DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort

Published:2020-09 Issue:3 Volume:73 Page:540-548
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Verna Elizabeth C.,Morelli Giuseppe,Terrault Norah A.,Lok Anna S.,Lim Joseph K.,Di Bisceglie Adrian M.,Zeuzem Stefan,Landis Charles S.,Kwo Paul,Hassan Mohamed,Manns Michael P.,Vainorius Monika,Akushevich Lucy,Nelson David R.,Fried Michael W.,Reddy K. Rajender

Funder

University of Florida

University of North Carolina at Chapel Hill

AbbVie

Bristol Myers Squibb

Gilead

GlaxoSmithKline

Janssen

Kadmon

Merck

Publisher

Elsevier BV

Subject

Hepatology

Reference22 articles.

1. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation;Goldberg;Gastroenterology,2017

2. Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy;Bunchorntavakul;J Viral Hepat,2016

3. The dynamic landscape of liver transplant in the era of effective HCV therapy;Verna;Hepatology,2017

4. Baseline factors associated with improvements in decompensated cirrhosis after direct-acting antiviral therapy for hepatitis C virus infection;El-Sherif;Gastroenterology,2018

5. Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: a European study;Belli;J Hepatol,2016

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic arterial infusion of autologous CD34+ cells for hepatitis C virus-related decompensated cirrhosis: A multicenter, open-label, exploratory randomized controlled trial;Regenerative Therapy;2024-12

2. Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia;The Lancet Regional Health - Western Pacific;2024-10

3. Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy;HPB;2024-08

4. EASL position paper on clinical follow-up after HCV cure;Journal of Hepatology;2024-08

5. Pharmacologic Treatment of Portal Hypertension;Clinics in Liver Disease;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3